These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23397075)

  • 21. Treatment of stage IIIB cervical cancer with Californium-252 fast-neutron brachytherapy and external photon therapy.
    Gallion HH; Maruyama Y; van Nagell JR; Donaldson ES; Rowley KC; Yoneda J; Beach JL; Powell DE; Kryscio RJ
    Cancer; 1987 May; 59(10):1709-12. PubMed ID: 3828944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up.
    Ishiyama H; Satoh T; Kitano M; Tabata K; Komori S; Ikeda M; Soda I; Kurosaka S; Sekiguchi A; Kimura M; Kawakami S; Iwamura M; Hayakawa K
    J Radiat Res; 2014 May; 55(3):509-17. PubMed ID: 24222312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
    Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
    Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts.
    Hjälm-Eriksson M; Ullén A; Johansson H; Levitt S; Nilsson S; Kälkner KM
    Acta Oncol; 2017 Jan; 56(1):21-26. PubMed ID: 27882806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy.
    Zhang W; Becciolini A; Biggeri A; Pacini P; Muirhead CR
    Breast Cancer Res; 2011 Apr; 13(2):R38. PubMed ID: 21463502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical report on external irradiation combined with californium-252 neutron intraluminal brachytherapy for cervical carcinoma treatment.
    Zhao H; Wang K; Sun J; Geng X; Zhang W
    Tumori; 2007; 93(6):636-40. PubMed ID: 18338506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cure of cervical cancer using 252Cf neutron brachytherapy.
    Maruyama Y; van Nagell JR; Yoneda J; Donaldson ES; Gallion HH; Higgins R; Kryscio RJ
    Strahlenther Onkol; 1990 May; 166(5):317-21. PubMed ID: 2190346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T; Ptácková B; Strnad V
    Strahlenther Onkol; 2003 Jun; 179(6):377-84. PubMed ID: 12789463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.
    Lönn S; Gilbert ES; Ron E; Smith SA; Stovall M; Curtis RE
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):464-74. PubMed ID: 20142245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of second cancers following breast cancer: role of the initial treatment.
    Rubino C; de Vathaire F; Diallo I; Shamsaldin A; Lê MG
    Breast Cancer Res Treat; 2000 Jun; 61(3):183-95. PubMed ID: 10965995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.
    Kotecha R; Yamada Y; Pei X; Kollmeier MA; Cox B; Cohen GN; Zaider M; Zelefsky MJ
    Brachytherapy; 2013; 12(1):44-9. PubMed ID: 22831750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.
    Patchell RA; Yaes RJ; Beach L; Kryscio RJ; Davis DG; Tibbs PA; Young B
    Br J Radiol; 1997 Nov; 70(839):1162-8. PubMed ID: 9536908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutron brachytherapy is better than conventional radiotherapy in advanced cervical cancer.
    Maruyama Y; Kryscio R; van Nagell JR; Yoneda J; Donaldson E; Hanson M; Beach JL; Feola JM; Martin A; Parker C
    Lancet; 1985 May; 1(8438):1120-2. PubMed ID: 2860334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
    Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
    BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutron interstitial brachytherapy for malignant gliomas: a pilot study.
    Patchell RA; Maruyama Y; Tibbs PA; Beach JL; Kryscio RJ; Young AB
    J Neurosurg; 1988 Jan; 68(1):67-72. PubMed ID: 2826722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contact neutron therapy of tumors with 252Cf irradiation].
    Vtiurin BM
    Med Radiol (Mosk); 1987 Sep; 32(9):62-7. PubMed ID: 3657457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
    Smolska-Ciszewska B; Miszczyk L; Białas B; Fijałkowski M; Plewicki G; Gawkowska-Suwińska M; Giglok M; Behrendt K; Nowicka E; Zajusz A; Suwiński R
    Radiat Oncol; 2015 Mar; 10():60. PubMed ID: 25884489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy).
    Aoki M; Miki K; Kido M; Sasaki H; Nakamura W; Kijima Y; Kobayashi M; Egawa S; Kanehira C
    J Radiat Res; 2014 May; 55(3):527-32. PubMed ID: 24351458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.